Sandusky, Ohio–(Newsfile Corp. – February 16, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today published an online, multimedia presentation detailing the Company’s CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning this year, in 2021 adding to the Company’s previously announced anticipated revenue for 2021.
PAO Group, Inc.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6729/74598_97ff1b4c0488d9d0_001full.jpg
Follow the links below to view the presentation as a Flipbook: PAOG Nutraceutical Development Expansion 2021 Or as a video:
Learn more about PAOG at www.paogroupinc.com.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.CONTACT INFORMATION
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/74598